Trial NCT03418571

View at ClinicalTrials.gov 
Org. Study IDs: ALX0171-C203

Last trial update was posted on 2019-07-30

MeSH Interventions

Gontivimab

MeSH Conditions

Communicable Diseases Infections Respiratory Tract Infections

Other Conditions

Respiratory Syncytial Virus Lower Respiratory Tract Infection

Stopping Reasons

The Sponsor decided to discontinue ALX-0171 development (due to insufficient evidence of efficacy). As a result, the ALX0171-C203 study was early terminated.

Limitations And Caveats

Based on the results of the Phase IIb study ALX0171-C201 (RESPIRE), the Sponsor decided to discontinue ALX-0171 development in infants and to early terminate the ALX0171-C203 study. Therefore, no data are available for the higher dose groups.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID